CMS Open Payments · Program Year 2024
Paragonix Technologies, Inc.
Paragonix Technologies, Inc. reported $3,968,522.57 across General Payments, Research, and Ownership to 1,200 physicians and teaching hospitals across 1,371 transactions.
- $4.0M Top quartile payer
- All-tracks total
- 1,371 Top quartile volume
- Transactions
- 1,200 Above-median reach
- Recipients
- +$1.5M
- General Payments vs PY2023
Paragonix Technologies, Inc. reported $3,968,522.57 across all CMS Open Payments tracks (General + Research + Ownership) to 1,200 physicians and teaching hospitals in Program Year 2024 - ranking #309 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $2,561,904.57, averaging $3.3K per recipient.
How Paragonix Technologies, Inc.'s $4.0M all-tracks total breaks down
Paragonix Technologies, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
37/100
Total payments
F
47/100
Transaction volume
F
20/100
Physician reach
F
19/100
Payment type diversity
D
63/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer paragonix-technologies-inc Paragonix Technologies, Inc.
$4.0M · #309/1,925 · 0.0% industry · PY2024
- TOT $4.0M
- RANK #309
- SHARE 0.0%
- TXN 1,371
- RCP 1,200
- CAT 5
- GEN $2.6M
- ΔGEN +$1.5M
- TOP1 42.1%
- PY 2024
Volume peers
Nearest volume peer: Illumina, Inc. ($4.0M)
Paragonix Technologies, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Paragonix Technologies, Inc.'s CMS-reported General Payments increased by $1.5M (+134.7%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: PARAGONIX TECHNOLOGIES, INC.PY2023: PARAGONIX TECHNOLOGIES, INC.PY2024: Paragonix Technologies, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $1,091,560.62
- PY2024
- $2,561,904.57
What the Data Shows for Paragonix Technologies, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Paragonix Technologies, Inc., that total blends General Payments (day-to-day consulting, meals, travel and speaking fees, shown separately above) with Research and Ownership/Investment interest records, each governed by its own CMS reporting rules. CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
Of the 5 general-payment categories charted below, "Consulting Fee" is the largest at $2.4M across 231 transactions, 94.9% of this company's General Payments (see our methodology for how research and ownership payments are reported separately).
General Payment Breakdown by Type
"Consulting Fee" leads Paragonix Technologies, Inc.'s 5-category general-payment breakdown at $2.4M, 94.9% of the reported total.
Paragonix Technologies, Inc. reports 5 general-payment categories - the top three are Consulting Fee (94.9%), Food and Beverage (3.2%), and Travel and Lodging (1.5%). The remaining 2 categories make up 0.4% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How Paragonix Technologies, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $2.4M | 231 | 94.9% |
| Food and Beverage | $83.0K | 851 | 3.2% |
| Travel and Lodging | $38.5K | 106 | 1.5% |
| Honoraria | $7.0K | 4 | 0.3% |
| Gift | $2.2K | 8 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,980,058.28 (77.3%) of $2,561,904.57 in this company's General Payments records across 433 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Paragonix Technologies, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Joseph Rubelowsky
$1,077,785.60 across 64 reported transactions
- 2
Alejandro Bribriesco
$371,572.68 across 44 reported transactions
- 3
Salil Deo
$350,200.00 across 40 reported transactions
- 4
Craig Jarrett
$103,000.00 across 16 reported transactions
- 5
Cristian Baeza
$77,500.00 across 14 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Paragonix Technologies, Inc. ranks #309 of 1,925 by total payments (top 16% by spend) but spreads that money notably more broadly than its spend rank alone would suggest -- #713 of 1,838 by HHI (top 39% most concentrated), a wider distribution than most similarly sized payers.
View all 12 companies in this HHI neighborhood as a list
- Activ Surgical, Inc. : $48.3K total payments, HHI 2249
- Haemonetics Corporation : $1.2M total payments, HHI 2247
- Actelion Pharmaceuticals, Ltd : $103.2K total payments, HHI 2241
- Catalyst OrthoScience : $619.0K total payments, HHI 2229
- CorMedix Inc. : $120.2K total payments, HHI 2228
- Peter Brasseler Holdings, LLC : $2.8M total payments, HHI 2223
- Paragonix Technologies, Inc. (this company) : $2.6M total payments, HHI 2220
- Freudenberg Medical, LLC : $88.80 total payments, HHI 2216
- Servier BioInnovation : $2.1K total payments, HHI 2211
- Endovascular Engineering Inc. : $44.3K total payments, HHI 2208
- Body Vision Medical Inc. : $17.5K total payments, HHI 2201
- Zevra Therapeutics Inc : $34.8K total payments, HHI 2200
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Paragonix Technologies, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Paragonix Technologies, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Paragonix Technologies, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Impulse Dynamics (USA) Inc.
Masimo Corporation
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
SmartHealth Inc
Amicus Therapeutics, Inc.
Put this to use
Paragonix Technologies, Inc. ranks #309 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See where Paragonix Technologies, Inc. sits among every top spender on the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Paragonix Technologies, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.